408 related articles for article (PubMed ID: 32396836)
1. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease.
Bayoumi A; Grønbæk H; George J; Eslam M
Trends Genet; 2020 Jun; 36(6):429-441. PubMed ID: 32396836
[TBL] [Abstract][Full Text] [Related]
2. Molecular epigenetic targets for liver diseases: current challenges and future prospects.
Zeidler R; de Freitas Soares BL; Bader A; Giri S
Drug Discov Today; 2017 Nov; 22(11):1620-1636. PubMed ID: 28754290
[TBL] [Abstract][Full Text] [Related]
3. Decoding liver injury: A regulatory role for histone modifications.
Tian W; Xu Y
Int J Biochem Cell Biol; 2015 Oct; 67():188-93. PubMed ID: 25801055
[TBL] [Abstract][Full Text] [Related]
4. Molecular signals of epigenetic states.
Bonasio R; Tu S; Reinberg D
Science; 2010 Oct; 330(6004):612-6. PubMed ID: 21030644
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study.
Wu YL; Lin ZJ; Li CC; Lin X; Shan SK; Guo B; Zheng MH; Li F; Yuan LQ; Li ZH
Signal Transduct Target Ther; 2023 Mar; 8(1):98. PubMed ID: 36864020
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modifications of histone and non-histone proteins in epigenetic regulation and translational applications in alcohol-associated liver disease: Challenges and research opportunities.
Rungratanawanich W; Ballway JW; Wang X; Won KJ; Hardwick JP; Song BJ
Pharmacol Ther; 2023 Nov; 251():108547. PubMed ID: 37838219
[TBL] [Abstract][Full Text] [Related]
7. Update on genetics and epigenetics in metabolic associated fatty liver disease.
Zhu X; Xia M; Gao X
Ther Adv Endocrinol Metab; 2022; 13():20420188221132138. PubMed ID: 36325500
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic modifications as new targets for liver disease therapies.
Zeybel M; Mann DA; Mann J
J Hepatol; 2013 Dec; 59(6):1349-53. PubMed ID: 23747756
[TBL] [Abstract][Full Text] [Related]
9. The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism.
Chen L; Huang W; Wang L; Zhang Z; Zhang F; Zheng S; Kong D
Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):259-270. PubMed ID: 32124651
[No Abstract] [Full Text] [Related]
10. Epigenetics in liver disease.
Mann DA
Hepatology; 2014 Oct; 60(4):1418-25. PubMed ID: 24633972
[TBL] [Abstract][Full Text] [Related]
11. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
Lu J; Huang Y; Zhang X; Xu Y; Nie S
Pharmacol Res; 2021 Aug; 170():105520. PubMed ID: 33639232
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics and vascular diseases.
Stratton MS; Farina FM; Elia L
J Mol Cell Cardiol; 2019 Aug; 133():148-163. PubMed ID: 31211956
[TBL] [Abstract][Full Text] [Related]
13. Multiple levels of epigenetic control for bone biology and pathology.
Montecino M; Stein G; Stein J; Zaidi K; Aguilar R
Bone; 2015 Dec; 81():733-738. PubMed ID: 25865577
[TBL] [Abstract][Full Text] [Related]
14. Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis.
Bure IV; Nemtsova MV; Kuznetsova EB
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628612
[TBL] [Abstract][Full Text] [Related]
15. Plant Immunity: From Signaling to Epigenetic Control of Defense.
Ramirez-Prado JS; Abulfaraj AA; Rayapuram N; Benhamed M; Hirt H
Trends Plant Sci; 2018 Sep; 23(9):833-844. PubMed ID: 29970339
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Regulation: A New Frontier for Biomedical Engineers.
Chen Z; Li S; Subramaniam S; Shyy JY; Chien S
Annu Rev Biomed Eng; 2017 Jun; 19():195-219. PubMed ID: 28301736
[TBL] [Abstract][Full Text] [Related]
17. Reversibility and heritability of liver fibrosis: Implications for research and therapy.
Atta HM
World J Gastroenterol; 2015 May; 21(17):5138-48. PubMed ID: 25954087
[TBL] [Abstract][Full Text] [Related]
18. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs.
Sadakierska-Chudy A; Filip M
Neurotox Res; 2015 Feb; 27(2):172-97. PubMed ID: 25516120
[TBL] [Abstract][Full Text] [Related]
20. Potential roles of noncoding RNAs in environmental epigenetic transgenerational inheritance.
Yan W
Mol Cell Endocrinol; 2014 Dec; 398(1-2):24-30. PubMed ID: 25224488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
